BOW participates to the EIC-ERC workshop on Gene and Cell Therapy


The EIC-ERC organised a workshop about Gene and Cell Therapy. The event was held online the 29th of June from 14:00 to 18:00 CET; even though the event was closed to the public, BOW participated on the activities and one of our partners, Antonella Bongiovanni, was a speaker in the “Thematic parallel sessions” about New vectors (viral and non-viral) for gene therapy. In this event the partners of BOW were able to highlight their knowledge on bio-nanotechnologies.


14:00 – 14:10: Welcome and Introduction

  • Jean-Pierre Bourguignon (President ad interim, ERC Scientific Council)
  • Mark Ferguson (Chair of the EIC Board)

14:10 – 14:50: Keynote speech

  • Luigi Naldini (SR-Tiget, San Raffaele Telethon Institute for Gene Therapy, Italy)

14:50 – 15:10: Plenary session: Current global Cell and Gene Therapy landscape and trends

  • Iordanis Arzimanoglou (Programme Manager EIC)

Break – 10 minutes

15:20 – Thematic parallel sessions

  1. Cell therapy, including stem cell therapy – Moderator: Margaret Buckingham (Institut Pasteur, France)
    • Giulio Cossu (University of Manchester, UK)
    • Michele De Luca (University of Modena and Reggio Emilia, Italy)
    • Carl Figdor (Radboud University, The Netherlands)
    • Magdalena Götz (Ludwig Maximilian University of Munich, Germany) Rogier Reijmers (Lumicks, The Netherlands)
    • Jérémie Laurent (Astraveus, France)
  2. Disease modelling including 3D-bioprinted organs/organoids and other Regenerative Medicine novel approaches – Moderator: Geneviève Almouzni (Institut Curie, France)
    • Hans Clevers (Hubrecht Institute for Developmental Biology and Stem Cell Research, The Netherlands)
    • Prisca Liberali (Friedrich Miescher Institute for Biomedical Research, Switzerland)
    • Christine Mummery (Leiden University, The Netherlands)
    • Matthias Lütolf (EPFL, Switzerland)
    • Øyvind Halaas (Norwegian University Science Technology, Norway)
    • Francesca M. Spagnoli (Centre for Stem Cells and Regenerative Medicine, King’s College London, UK)
  1. New vectors (viral and non-viral) for gene therapy – Moderator: Marja Makarow (BioCenter, Finland)
    • Stein Aerts (Flemish Institute for Biotechnology – KU Leuven, Belgium)
    • Zsuzsanna Izsvák (Max Delbrück Centrum for Molecular Medicine, Germany)
    • Federico Mingozzi (Association GENETHON, France & Spark Therapeutics, US)
    • Seppo Ylä-Herttuala (University of Eastern Finland, Finland) Anna Pedrix Rosell (Sixfold Bioscience Ltd, The Imperial College White City Inc Innovation Hub, UK)
    • Antonella Bongiovanni (CNR – Institute of Biomedical Research and Innovation in Palermo, Italy)
  1. Novel gene therapy approaches including RNA-based technologies – Moderator: NektariosTavernarakis (Foundation for Research and Technology, Greece)
  • Roman Jerala (National Institute of Chemistry, Slovenia)
  • Thorsten Stafforst (University of Tübingen, Germany)
  • Molly Stevens (Imperial College London, UK)
  • Pieter Vader (University of Utrecht, The Netherlands) Sven Panke (ETH, Switzerland)
  • Stéphane Boissel (Sparingvision, France)

Break – 10 minutes

  1. 17:00 – 18:00: Roundtable discussion on transition from research to innovation in Cell and Gene Therapy with – Moderator: Brady Huggett (Senior Editor of Nature Biotechnology)
    • Niccolo Bacchi (Novo Ventures, Denmark)
    • Alessandra Biffi (University of Padua, Italy & Harvard Stem Cell Institute, US)
    • Deniz Kirik (Lund University, Sweden)
    • Jo Bury (Flemish Institute for Biotechnology, Belgium)
    • Erik Gatenholm (Cellink, US, EU)
    • Irene Norstedt (European Commission)

18:00 – 18:05: Conclusions